130 related articles for article (PubMed ID: 1741053)
1. AIDS vaccine developments.
Le Grand R; Vaslin B; Vogt G; Roques P; Humbert M; Dormont D
Nature; 1992 Feb; 355(6362):684. PubMed ID: 1741053
[No Abstract] [Full Text] [Related]
2. AIDS vaccine developments.
Cranage MP; Ashworth LA; Greenaway PJ; Murphey-Corb M; Desrosiers RC
Nature; 1992 Feb; 355(6362):685-6. PubMed ID: 1741055
[No Abstract] [Full Text] [Related]
3. AIDS vaccine developments.
Osterhaus A; de Vries P; Heeney J
Nature; 1992 Feb; 355(6362):684-5. PubMed ID: 1741054
[No Abstract] [Full Text] [Related]
4. Specific and non-specific immunity and protection of macaques against SIV infection.
Le Grand R; Vogt G; Vaslin B; Roques P; Théodoro F; Aubertin AM; Dormont D
Vaccine; 1992; 10(12):873-9. PubMed ID: 1455913
[TBL] [Abstract][Full Text] [Related]
5. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus.
Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714
[TBL] [Abstract][Full Text] [Related]
6. Perpetuation of vaccine memory T cell responses against SIV/HIV.
Lévy Y
EMBO Mol Med; 2011 Sep; 3(9):507-9. PubMed ID: 21830302
[No Abstract] [Full Text] [Related]
7. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.
Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G
J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
9. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
Biberfeld G; Thorstensson R; Putkonen P
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
[No Abstract] [Full Text] [Related]
10. Vaccine studies with the 32H reisolate of SIVmac251: an overview.
Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987
[No Abstract] [Full Text] [Related]
11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
[TBL] [Abstract][Full Text] [Related]
13. Live virus shows promise as AIDS vaccine.
Minn Med; 1993 Feb; 76(2):52. PubMed ID: 8433695
[No Abstract] [Full Text] [Related]
14. Moving ahead an HIV vaccine: use both arms to beat HIV.
Walker BD; Ahmed R; Plotkin S
Nat Med; 2011 Oct; 17(10):1194-5. PubMed ID: 21988996
[No Abstract] [Full Text] [Related]
15. Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection.
Stahl-Hennig C; Voss G; Nick S; Petry H; Fuchs D; Wachter H; Coulibaly C; Lüke W; Hunsmann G
Virology; 1992 Feb; 186(2):588-96. PubMed ID: 1733103
[TBL] [Abstract][Full Text] [Related]
16. Summary of the SIV Working Group.
Schultz AM
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977
[No Abstract] [Full Text] [Related]
17. SIV vaccines, 1991--a year in review.
Gardner MB; Hu SL
AIDS; 1991; 5 Suppl 2():S115-27. PubMed ID: 1845043
[No Abstract] [Full Text] [Related]
18. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
19. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
20. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
